Fogpharma
FogPharma creates a new class of medicines that target human disease drivers currently considered undruggable.
3
Funding Rounds
$351.0m
Money raised
Overview
FogPharma creates a new class of medicines that target human disease drivers currently considered undruggable.
- Website:
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Fogpharma has raised a total of $66m in funding over 3 rounds.
Key Insights:
- Fogpharma Series B round, May 2018: $66m
- Fogpharma Series C round, March 1, 2021: $107m
- Fogpharma Series D round, November 21, 2022: $178m
Fogpharma Series B round, May 2018
$66m
Fogpharma Series C round, March 1, 2021
$107m
Fogpharma Series D round, November 21, 2022
$178m
Industries
Fogpharma is active in the following industries: